Cargando…
Soluble perlecan domain i enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells
BACKGROUND: Immobilized recombinant perlecan domain I (PlnDI) binds and modulates the activity of heparin-binding growth factors, in vitro. However, activities for PlnDI, in solution, have not been reported. In this study, we assessed the ability of soluble forms to modulate vascular endothelial gro...
Autores principales: | Muthusamy, Arivalagan, Cooper, Carlton R, Gomes, Ronald R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987766/ https://www.ncbi.nlm.nih.gov/pubmed/21047416 http://dx.doi.org/10.1186/1471-2091-11-43 |
Ejemplares similares
-
Cloning and Optimization of Soluble Vascular Endothelial Growth Factor(165) Expression in Escherichia coli
por: Salimi, Ali, et al.
Publicado: (2016) -
Effects of Vascular Endothelial Growth Factor 165 on Bone Tissue Engineering
por: Feng, Lin, et al.
Publicado: (2013) -
Production of Soluble Human Vascular Endothelial Growth Factor VEGF-A(165)-Heparin Binding Domain in Escherichia coli
por: Seyedarabi, Arefeh, et al.
Publicado: (2013) -
Perlecan deficiency causes endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase
por: Nonaka, Risa, et al.
Publicado: (2015) -
Transplantation of vascular endothelial growth factor 165-transfected endothelial progenitor cells for the treatment of limb ischemia
por: WANG, SHENG, et al.
Publicado: (2015)